James Sabry Insider Profile
4 Followers
James Sabry, Former Executive Chairman at Cytokinetics, holds 0.00 shares in Cytokinetics (Ticker: CYTK). Most recently, James Sabry Sold 25,000 shares of Cytokinetics on Jun 04, 2010 for an estimated value of $72.93K.
James Sabry's Trading History
| CYTKCytokinetics | Jun 04, 2010 | Former Executive Chairman | Informative Sell | 72.93K | $0.00 | |
CYTK Insider Shares: 0.00 (0.00%) | ||||||
You May Also Like
James Sabry insider profile FAQ
What is the percentage of profitable transactions made by James Sabry?
The percentage of profitable transactions made by James Sabry is 71%.
What is the average return per transaction made by James Sabry?
The average return per transaction made by James Sabry is 20.50%.
What stocks does James Sabry hold?
James Sabry holds: CYTK stocks.
What was James Sabry’s latest transaction?
James Sabry’s latest transaction was an Informative Sell of $72.93K.
What was James Sabry's most profitable transaction?
James Sabry’s most profitable transaction was an Informative Sell of CYTK stock on April 28, 2010. The return on the trade was 53.10%.
What is James Sabry's role in Cytokinetics?
James Sabry's role in Cytokinetics is Former Executive Chairman.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.
